Nanopolymeric systems to improve brain cancer treatment outcomes

Luiza Steffens, Mabilly Cox Holanda De Barros Dias, Pablo Ricardo Arantes, Jeferson Gustavo Henn, Michael Nugent, Dinara Jaqueline Moura

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Brain tumors, especially glioblastomas, are an unsolved clinical problem and a challenge for the current medical science given the limitations of conventional therapies. Brain physiology has distinct characteristics and to overcome them, several strategies using distribution systems are being developed, including polymeric nanoproducts, such as nanoparticles and nanofibers. These systems are usually stable in biological fluids, making them a promising approach to provide controlled and targeted release of drugs, thereby reducing toxicity following systemic administration. Moreover, molecular changes are extremely important to understand GBs and this knowledge could potentially be used for the design of targeted therapy. In this chapter, our focus and main interest will be on nanopolymeric systems, its various types, their efficacy and impact on brain cancer therapy, more specifically on GB treatment, how they can bring enhancements in the efficiency of traditional chemotherapy drugs and how to study polymeric interactions with drugs with multiscale computational methods.

Original languageEnglish
Title of host publicationAdvances and Challenges in Pharmaceutical Technology
Subtitle of host publicationMaterials, Process Development and Drug Delivery Strategies
PublisherElsevier
Pages355-394
Number of pages40
ISBN (Electronic)9780128200438
ISBN (Print)9780128200438
DOIs
Publication statusPublished - 1 Jan 2021

Keywords

  • Drug delivery systems
  • Glioblastoma
  • Nanofibers
  • Nanoparticles
  • Nanoproducts
  • Nanotechnology

Fingerprint

Dive into the research topics of 'Nanopolymeric systems to improve brain cancer treatment outcomes'. Together they form a unique fingerprint.

Cite this